178 related articles for article (PubMed ID: 32325489)
21. Circ-UBR5: An exonic circular RNA and novel small nuclear RNA involved in RNA splicing.
Qin M; Wei G; Sun X
Biochem Biophys Res Commun; 2018 Sep; 503(2):1027-1034. PubMed ID: 29944885
[TBL] [Abstract][Full Text] [Related]
22. A Tunable Brake for HECT Ubiquitin Ligases.
Chen Z; Jiang H; Xu W; Li X; Dempsey DR; Zhang X; Devreotes P; Wolberger C; Amzel LM; Gabelli SB; Cole PA
Mol Cell; 2017 May; 66(3):345-357.e6. PubMed ID: 28475870
[TBL] [Abstract][Full Text] [Related]
23. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
[TBL] [Abstract][Full Text] [Related]
24. Genomic landscape and prognostic analysis of mantle cell lymphoma.
Yang P; Zhang W; Wang J; Liu Y; An R; Jing H
Cancer Gene Ther; 2018 Jun; 25(5-6):129-140. PubMed ID: 29755111
[TBL] [Abstract][Full Text] [Related]
25. Gene mutations and actionable genetic lesions in mantle cell lymphoma.
Ahmed M; Zhang L; Nomie K; Lam L; Wang M
Oncotarget; 2016 Sep; 7(36):58638-58648. PubMed ID: 27449094
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of HECT domain of UBE3C E3 ligase and its ubiquitination activity.
Singh S; Sivaraman J
Biochem J; 2020 Mar; 477(5):905-923. PubMed ID: 32039437
[TBL] [Abstract][Full Text] [Related]
27. BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer.
Yan Y; Zhou B; Lee YJ; You S; Freeman MR; Yang W
Proteomics; 2022 Feb; 22(4):e2100172. PubMed ID: 34897998
[TBL] [Abstract][Full Text] [Related]
28. The E3 ubiquitin ligase UBR5 interacts with TTC7A and may be associated with very early onset inflammatory bowel disease.
Dhingani N; Guo C; Pan J; Li Q; Warner N; Jardine S; Leung G; Kotlarz D; Gonzaga-Jauregui C; Klein C; Snapper SB; Navas-López VM; Muise AM
Sci Rep; 2020 Oct; 10(1):18648. PubMed ID: 33122718
[TBL] [Abstract][Full Text] [Related]
29. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis.
Zhong Q; Gao W; Du F; Wang X
Cell; 2005 Jul; 121(7):1085-95. PubMed ID: 15989957
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance.
Kim A; Seong KM; Kang HJ; Park S; Lee SS
Oncotarget; 2015 Nov; 6(35):38225-38. PubMed ID: 26517678
[TBL] [Abstract][Full Text] [Related]
31. Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5.
Panfil AR; Al-Saleem J; Howard CM; Shkriabai N; Kvaratskhelia M; Green PL
Front Microbiol; 2018; 9():80. PubMed ID: 29441057
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin V(H) gene mutational analysis suggests that blastic variant of mantle cell lymphoma derives from different stages of B-cell maturation.
László T; Nagy M; Kelényi G; Matolcsy A
Leuk Res; 2000 Jan; 24(1):27-31. PubMed ID: 10634642
[TBL] [Abstract][Full Text] [Related]
33. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
[TBL] [Abstract][Full Text] [Related]
34. A review: targeting UBR5 domains to mediate emerging roles and mechanisms: chance or necessity?
Wang Y; Niu K; Shi Y; Zhou F; Li X; Li Y; Chen T; Zhang Y
Int J Surg; 2024 May; ():. PubMed ID: 38701508
[TBL] [Abstract][Full Text] [Related]
35. BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma.
Bullinger L; Leupolt E; Schaffner C; Mertens D; Bentz M; Lichter P; Döhner H; Stilgenbauer S
Leukemia; 2000 Aug; 14(8):1490-2. PubMed ID: 10942247
[TBL] [Abstract][Full Text] [Related]
36. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma.
Rinaldi A; Kwee I; Taborelli M; Largo C; Uccella S; Martin V; Poretti G; Gaidano G; Calabrese G; Martinelli G; Baldini L; Pruneri G; Capella C; Zucca E; Cotter FE; Cigudosa JC; Catapano CV; Tibiletti MG; Bertoni F
Br J Haematol; 2006 Feb; 132(3):303-16. PubMed ID: 16409295
[TBL] [Abstract][Full Text] [Related]
37. Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response.
Song M; Wang C; Wang H; Zhang T; Li J; Benezra R; Chouchane L; Sun YH; Cui XG; Ma X
Oncoimmunology; 2020; 9(1):1746148. PubMed ID: 32363114
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma.
Hansen MH; Cédile O; Blum MK; Hansen SV; Ebbesen LH; Bentzen HHN; Thomassen M; Kruse TA; Kavan S; Kjeldsen E; Kristensen TK; Haaber J; Abildgaard N; Nyvold CG
Exp Hematol; 2020 Apr; 84():7-18.e12. PubMed ID: 32173361
[TBL] [Abstract][Full Text] [Related]
39. The HECT domain of TRIP12 ubiquitinates substrates of the ubiquitin fusion degradation pathway.
Park Y; Yoon SK; Yoon JB
J Biol Chem; 2009 Jan; 284(3):1540-9. PubMed ID: 19028681
[TBL] [Abstract][Full Text] [Related]
40. BMI1-UBR5 axis regulates transcriptional repression at damaged chromatin.
Sanchez A; De Vivo A; Uprety N; Kim J; Stevens SM; Kee Y
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11243-11248. PubMed ID: 27647897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
